Cargando…
A proliferative subtype of colorectal liver metastases exhibits hypersensitivity to cytotoxic chemotherapy
Personalized treatment approaches for patients with limited liver metastases from colorectal cancer are critically needed. By leveraging three large, independent cohorts of patients with colorectal liver metastases (n = 336), we found that a proliferative subtype associated with elevated CIN70 score...
Autores principales: | Spurr, Liam F., Martinez, Carlos A., Katipally, Rohan R., Iyer, Soumya C., Pugh, Sian A., Bridgewater, John A., Primrose, John N., Domingo, Enric, Maughan, Timothy S., D’Angelica, Michael I., Talamonti, Mark, Posner, Mitchell C., Connell, Philip P., Weichselbaum, Ralph R., Pitroda, Sean P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9568565/ https://www.ncbi.nlm.nih.gov/pubmed/36241710 http://dx.doi.org/10.1038/s41698-022-00318-z |
Ejemplares similares
-
Association between miR-31-3p expression and cetuximab efficacy in patients with KRAS wild-type metastatic colorectal cancer: a post-hoc analysis of the New EPOC trial
por: Pugh, Siân, et al.
Publicado: (2017) -
T cells but not NK cells are associated with a favourable outcome for resected colorectal liver metastases
por: Pugh, Siân A, et al.
Publicado: (2014) -
microRNAs and oligometastasis
por: Khodarev, Nikolai N., et al.
Publicado: (2015) -
Oligometastatic prostate cancer: Reality or figment of imagination?
por: Foster, Corey C., et al.
Publicado: (2018) -
Treatment of Cancer with Radio-Immunotherapy: What We Currently Know and What the Future May Hold
por: Turchan, William Tyler, et al.
Publicado: (2021)